How we rate providers: Transparent, patient-first scoring β†’
LIV by WellNow homepage showing GLP-1 weight loss services

LIV by WellNow

LIV by WellNow homepage showing GLP-1 weight loss services
LIV by WellNow
Our Review
Liv by WellNow earns a 3.5 out of 5 from our editorial team β€” a solid option for straightforward, affordable compounded semaglutide with legitimate medical backing, but limited in clinical depth and patient support. Its strengths are transparent all-inclusive pricing at $279/month and the credibility of WellNow's urgent care network. The main concerns are the absence of dietitian coaching, lab monitoring, and independent patient reviews. Liv is best suited for self-directed patients who want affordable GLP-1 access from a medically credible source without paying for wraparound services they won't use.
Clinical Quality
Support
Patient Protection
Cost & Value
Access
Trust & Transparency
Authenticity
Reputation
Reader Rating0 Votes
What We Like
A BBB rating
Pricing: $279
Nationwide telehealth
What Could Be Better
No/minimal Trustpilot reviews
No lab testing
No dietitian access
Unknown CoA testing for compounded meds
No insurance accepted
3.5
Competitive but Mixed
πŸ’Š
Medications
Compounded semaglutide
πŸ’°
Monthly Cost
$279
⚑
Speed to Start
Fast
⭐
Trustpilot
Not yet rated
βœ“ Verified Provider
Compounded Medications
Est. 2023

About LIV by WellNow

Liv by WellNow entered the telehealth weight loss market in 2023 as the digital health extension of WellNow Urgent Care, a network of over 100 brick-and-mortar urgent care clinics across the eastern United States. That clinical infrastructure gives Liv a differentiator most pure-play telehealth startups lack: every prescription is backed by an established medical organization with real exam rooms, lab capabilities, and in-person providers. For patients who worry about the “faceless app” feel of many online weight loss programs, Liv’s urgent care parentage offers a measure of reassurance.

The program revolves around compounded semaglutide, dispensed at a flat 9 per month that covers the medication, provider consultations, and shipping. There are no hidden titration fees or separate pharmacy charges β€” what you see is what you pay. That all-inclusive pricing puts Liv in the mid-range of the compounded semaglutide market, slightly above budget options but well below brand-name alternatives. Patients should understand, however, that compounded medications are not FDA-approved finished products and are prepared by 503B outsourcing pharmacies rather than the original manufacturer.

Liv holds an A rating with the Better Business Bureau, which signals satisfactory complaint resolution and business transparency. The platform does not yet have a Trustpilot presence, so independent review data is limited. Our editorial team found the onboarding process straightforward β€” a brief health questionnaire, asynchronous provider review, and medication shipped to your door β€” but the overall support model is moderate. You will have access to a prescribing provider for check-ins, though Liv does not offer the dedicated dietitian coaching or behavioral programming seen in higher-tier competitors.

One area where Liv falls short compared to comprehensive platforms is clinical depth. There is no integrated lab testing, no structured nutrition curriculum, and no mental health or behavioral component. The program is fundamentally a prescription service with medical oversight rather than a holistic weight management program. For patients who are self-motivated and primarily need affordable access to GLP-1 medication, that simplicity may actually be a virtue. For those who need accountability and lifestyle guidance, it may not be enough.

Liv is best understood as a clinically-backed, no-frills compounded semaglutide service at a competitive price point. The WellNow urgent care pedigree adds legitimacy, the flat pricing eliminates surprise costs, and the BBB rating suggests reasonable business practices. It is not a full-spectrum weight loss program, and patients seeking brand-name medications, insurance billing, or intensive coaching should look elsewhere.

At a Glance

Medications Offered

Compounded semaglutide

Compounded

Cost & Insurance

  • Monthly: $279
  • 6-month estimate: $1,674
  • Insurance: No
  • Self-pay: Yes

Clinical Features

  • Lab testing: No
  • Dietitian access: No
  • Verified Pharmacy: WellNow Urgent Care pharmacy network
  • BBB Rating: A

Delivery & Access

  • Format: Subcutaneous
  • Nationwide telehealth: No (currently PA, NY, IL, IN, MI)
  • Speed: Fast
  • Spanish-speaking providers: Not available

From the Inside

What the LIV by WellNow Intake Looks Like

We walked through LIV by WellNow’s GLP-1 intake ourselves. LIV uses a single-page Compounded Semaglutide Eligibility Form rather than a step-by-step wizard β€” the form is short, but the clinical screening packed into it is among the most comprehensive in the catalog. The notable trade-off is geographic: LIV currently operates in only five states.

8
Total Screens
~5 min
Time to Complete
8
Distinct Stages
Clinical Rigor
7/ 10

Strong for an 8-screen flow. Pancreatitis, MEN-2, MTC, semaglutide-specific allergy, chronic kidney disease, insulin-dependent diabetes, ACTIVE OR PAST EATING DISORDER (anorexia/bulimia named explicitly), and pregnancy/breastfeeding/TTC all appear in a single conditions multi-select. Missing PHQ, substance/alcohol depth, BP/HR.

Friction Level
4/ 10

Low. Single-page form, no account-creation gate, no marketing testimonial walls, and no fake-urgency timers. The main friction sources are pricing ($747 quarterly upfront or $279/mo) and the 5-state geographic limit. Patient identity is captured at the eligibility-result screen rather than up-front.

The 8 Stages

Stage 1
Body Metrics & GLP-1 Recency
Date of birth, height in feet/inches, weight in pounds, then a Y/N on whether the patient is currently or has recently (last 6 months) taken a GLP-1 β€” explicitly named: semaglutide, tirzepatide, liraglutide, Ozempic, Wegovy, Zepbound
Stage 2
Health Conditions Multi-select
9-option multi-select naming pancreatitis, “MEN-2 personal/family OR MTC personal,” semaglutide allergy (Wegovy/Ozempic named), chronic kidney disease, diabetes requiring insulin, insulin resistance/T2D, active or past eating disorder (anorexia/bulimia/other), pregnant/breastfeeding/TTC, none
Stage 3
Medications & Allergies
“Do you currently take any medications?” Y/N (with follow-up if yes), “Do you have any allergies to medications?” Y/N, “Do you currently smoke or vape nicotine?” Y/N β€” three short follow-ups stacked under the conditions multi-select
Stage 4
Diet, Exercise & Identity
“Have you tried to lose weight via diet and exercise in the past?” Y/N, exercise frequency 5-option scale (once / twice / 3-5x / would like help starting / prefer not to say), sex assigned at birth (M/F), gender identity (Man/Woman/Non-binary/Prefer not to say), free-text additional info for the provider
Stage 5
Eligibility Result
“Great news, you are eligible for compounded semaglutide!” β€” instant on-form result. Then a single panel asks first/last name, email, phone, street address (no PO boxes), apartment, city, state, ZIP for account setup
Stage 6
5-State Geographic Limit
The state dropdown lists only Illinois, Indiana, Michigan, New York, and Pennsylvania β€” patients in any other state cannot complete the address. The narrowest service area we have observed in the catalog
Stage 7
Membership Selection
Weight Loss 3-Month Membership at $747 per quarter ($249/mo, ships every 12 weeks, $30/mo savings vs monthly) or Weight Loss Monthly Membership at $279/month β€” both auto-renewing, both billed upfront for the full membership period
Stage 8
Payment
Order summary with $747 subtotal + $16.81 tax = $763.81 total (or $279 + tax for monthly), billing address, credit/debit card capture. No PayPal observed. Coupon code field available

Clinical Safety Screens Performed

βœ“ MEN-2 personal/family OR MTC personal (combined option)
βœ“ Pancreatitis personal history
βœ“ Active or past eating disorder (anorexia/bulimia named)
βœ“ Pregnancy / breastfeeding / TTC
βœ“ Semaglutide-specific allergy (Wegovy/Ozempic named)
βœ“ General medication allergy Y/N follow-up
βœ“ CKD, insulin-dependent T2D, insulin resistance
βœ“ Smoking / vaping nicotine
βœ“ Diet/exercise history Y/N + frequency scale
βœ“ Free-text “additional info for provider”
πŸ—Ί 5-State Geographic Limit (IL, IN, MI, NY, PA)

The state dropdown on the account-setup screen lists only Illinois, Indiana, Michigan, New York, and Pennsylvania. Patients outside these five states cannot complete the address and will be unable to start a membership. This is the narrowest service area in our catalog β€” most direct-to-consumer GLP-1 platforms operate nationwide. LIV by WellNow appears to operate as a regional clinic chain offering compounded semaglutide via telehealth; the geographic constraint reflects state-by-state telehealth licensure and pharmacy distribution, not patient-side limits.

βœ… Eating-Disorder Screen Named Explicitly

LIV is one of the platforms in our catalog that names “active or past diagnosis of an eating disorder (e.g. anorexia, bulimia, or other)” as a discrete option in the conditions multi-select. For a medication class with documented appetite-suppression and binge-eating-disorder considerations, asking the question by name β€” rather than burying it in a generic mental-health checkbox or omitting it entirely β€” is a meaningful clinical choice. Pregnancy, breastfeeding, and trying-to-conceive are similarly named explicitly.

⚠ What the LIV Intake Doesn’t Ask

No validated PHQ-2 or PHQ-9 mental-health instrument and no suicidality. No substance or alcohol screen beyond the smoking/vaping Y/N. No current-medication review depth beyond a Y/N gate. No blood pressure or resting heart rate. No MEN-2 separate from MTC β€” the two are combined into one checkbox option. No ID upload. No phone OTP. The single-page format is efficient but means clinical depth on any one dimension is necessarily shallower than a multi-screen wizard would allow.

Source: GLP-1.Reviews editorial walkthrough on April 29, 2026. We completed every screen of the LIV by WellNow Compounded Semaglutide Eligibility Form using a representative GLP-1 candidate persona and stopped before submitting payment.

Visit LIV by WellNow β†’

Opens liv.wellnow.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you. LIV is currently available in IL, IN, MI, NY, and PA only.

Visit LIV by WellNow β†’

Start your GLP-1 weight loss journey with LIV by WellNow today

Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.

Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.

LIV by WellNow
3.5 / 5.0
Competitive

Let's Review Widget